Detalhe da pesquisa
1.
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.
Blood
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484137
2.
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
Cancer
; 125(11): 1830-1836, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30707764
3.
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.
J Clin Oncol
; 42(4): 467-480, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38079587
4.
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma.
bioRxiv
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328071